Profile

Dr. Lindsey Shultz

Public Health Advisor, The Pandemic Tracking Collective

Lindsey is a physician and public health analyst from Pittsburgh, PA. She was a member of the Science Communication team at The COVID Tracking Project at The Atlantic and served as a senior science advisor and team lead for COVID Explained and COVID Act Now. Her broader interests include harm reduction, bioethics, and health systems.  Both prior to and after graduate school, she worked with Prevention Point Pittsburgh focusing on evidence-based drug policy. She received her undergraduate degrees from the Carnegie Mellon University Science and Humanities Scholars program in Biological Sciences and Ethics, History, and Public Policy. She earned her MD from Weill Cornell Medical College, where she was awarded The Gustave J. Noback Memorial Prize in Anatomy for student instruction, and trained for her MPH at Columbia University where she focused on the implementation of scientifically rigorous policy reform at both a national and international level. Lindsey was a 4-time jeopardy champion and a semi-finalist in the 2019 Tournament of Champions.

Authored Content

  • Feb 16 2022
    Blueprint Tracking SARS-CoV-2 and Its Variants in Wastewater: An Old Technique Is Yielding Powerful New Insights in the Covid-19 Pandemic The newest addition to the Centers for Disease Control and Prevention’s (CDC) Covid Data Tracker reports on levels of SARS-CoV-2 RNA in wastewater. While researchers, public health departments, and some private companies have been monitoring wastewater since the beginning of the pandemic, this tracker marks an important step in the establishment of the National Wastewater Surveillance System […] Dave Luo, Dr. Rick Bright, Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Lindsey Shultz, Megan Diamond
  • Dec 28 2021
    Field Note Vaccine Inequity Increases the Risk of New SARS-CoV-2 Variants Emerging Robust genomic surveillance, along with transparency, communication, and global collaboration, is needed to detect and control emerging variants. To control the Covid-19 pandemic, the World Health Organization (WHO) called on member states to meet a goal of vaccinating 40% of their population by the end of 2021. As of mid December 2021, over 8.6 billion […] Dave Luo, Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Lindsey Shultz
  • Dec 22 2021
    Field Note Tracking State Reporting of Covid-19 Vaccine Breakthrough Infections Today, we are releasing a reporting scorecard that evaluates U.S. state data reporting for Covid-19 vaccine breakthrough infections (BI) against best practices we have identified. We assign states letter grades based on their alignment with these best practices for reporting BI data and will update the grades monthly to monitor progress. The scorecard with states’ […] Dave Luo, Jennifer Clyde, Jessica Malaty Rivera, Jonathan Gilmour, Kaitlyn Johnson, Kara Schechtman, Leo Wolansky, Lindsey Shultz, Michal Mart, Rebecca Glassman
  • Dec 01 2021
    Blog Post Genomic Surveillance Is Essential To Track Covid-19 Variants in Both Unvaccinated and Vaccinated Populations Technological advancements have made sequencing quicker and more affordable, but collaboration, outreach, and trust are needed to achieve representative samples from underserved populations. The course of the Covid-19 pandemic depends not only on how the SARS-CoV-2 virus changes, but on how communities respond to it. Public health officials can only make decisions to protect their […] Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
  • Nov 09 2021
    Blog Post The Critical Challenge of Tracking Breakthrough Infections, and Why We Still Need Better Data Standards Despite ample vaccine supplies, outbreaks among unvaccinated populations in the US and the appearance of the Delta variant promote infection in fully vaccinated individuals. These breakthrough infections must be carefully tracked. As the percentage of Americans considered fully vaccinated reached 58 percent, and Covid-19-related deaths surpassed three quarters of a million, concerns over breakthrough infections […] Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
Back to Top